The renewal window for most manufacturer prescription assistance programs closes on April 30, 2026 — a deadline that, until recently, Gladys Ochoa had no idea existed.
I met Gladys in late January at a Walgreens pharmacy counter in Denver’s Capitol Hill neighborhood. She was standing ahead of me in line, speaking quietly to the pharmacist about whether the store kept any information on drug company assistance programs. Her voice had the particular calm of someone who has practiced not sounding panicked. When she turned around and noticed me writing in a reporter’s notebook, she paused — and then, after a short conversation outside, agreed to sit down and talk.
What she told me over the next two hours in a nearby coffee shop was a story about the specific, grinding way a single financial surprise can destabilize a life that looked, from the outside, entirely intact.
The Life That Looked Fine on Paper
Gladys Ochoa is 49 years old. She manages a mid-size home goods retail store in Denver, a job that pays her roughly $78,000 a year — solid income by most measures, and enough, she told me, to feel like the hard years were behind her. She has a five-year-old daughter, Mia, from a relationship that ended in 2022. She holds a master’s degree in business administration from the University of Colorado Denver, which she earned in 2019.
She also carries $44,800 in federal student loan debt from that degree, currently on an income-driven repayment plan she’s maintained without interruption since 2021. Her monthly payment runs approximately $390. That was the financial weight she knew about and had accounted for.
The Debt She Didn’t Know She Owed
In March of 2025, Gladys received a certified letter from a debt collections agency. Her ex-partner — Mia’s father, from whom she had separated in 2022 — had accumulated $23,400 on a joint credit card that she told me she had forgotten existed. The account was opened during the relationship for home repairs, sat dormant as far as she knew, and was quietly run up and left unpaid for nearly two years after the separation ended.
Because her name was on the account, she was equally liable for the full balance. Within 60 days of the first collections contact, her credit score — which had held at 714 — dropped to 569.
The Consumer Financial Protection Bureau notes that joint account holders share full legal responsibility for a debt regardless of which party made the charges — a fact Gladys said she was not aware of when the account was originally opened.
The score drop itself was the beginning, not the end. What followed was a series of secondary consequences she had not mapped out in advance — the most immediate of which had nothing to do with borrowing money.
How a Routine Insurance Switch Became a Crisis
Gladys has managed chronic migraines for eight years. For the past three, she’s been prescribed a CGRP inhibitor — a class of newer preventive medications that can run between $600 and $900 per month at retail price without assistance. Under her previous employer-sponsored plan, her monthly copay was $45. That coverage had been stable long enough that she stopped thinking about it.
In January 2026, her employer switched insurance carriers as part of an annual renewal. The new plan classified her migraine medication as a Tier 4 specialty drug. Her monthly out-of-pocket cost jumped from $45 to $680 — overnight, with no prior notification she recalled receiving.
“Nobody warned me,” she told me. “I got the new insurance card in the mail and thought nothing of it. I found out at the pharmacy window when they told me my total.”
She could not absorb that cost — not with $390 in monthly loan payments, full solo childcare expenses for Mia, and now a $23,400 collections debt blocking her from accessing any refinancing options. Her high income, she told me, had made her feel like she shouldn’t be in this position. That feeling, she admitted, delayed her from asking for help by several weeks.
The Prescription Assistance Window She Almost Missed
The pharmacist Gladys spoke with at Walgreens — the conversation I overheard — pointed her toward the drug manufacturer’s direct patient support program. She had also heard of NeedyMeds, a nonprofit database that aggregates pharmaceutical assistance programs and state-level drug cost resources.
Gladys spent a weekend in early February completing applications. The process, she told me, was more involved than she had expected — it required her 2024 tax return, a letter from her employer confirming active insurance coverage, and a signed form from her neurologist. She described the documentation phase as “a part-time job I didn’t have time for.”
When she described receiving the approval letter, her voice shifted in a way that was audible even in a noisy coffee shop. “When I got it, I cried,” she told me. “Not just because of the money, though it was a lot. It meant I could keep taking the medication that actually works. For the first time in months, I felt like I had some ground under my feet.”
The Ground That Still Feels Uncertain
The prescription win is real. But when I asked Gladys how she feels about the larger picture, her answer was measured in a way that felt earned rather than rehearsed.
The $23,400 collections debt remains active. She is working with a consumer law attorney to determine whether she has grounds to dispute her liability — given that she received no statements and the charges were made after the separation. That process, she said, could take months and carries no guarantee of outcome.
Her credit score has moved from 569 to 591 since she established a formal monthly payment arrangement with the collections agency. According to CFPB credit reporting guidance, a collections account can remain on a credit report for up to seven years from the date of first delinquency, regardless of whether payments are being made.
Her student loans, she noted, were untouched by the credit drop — they remain in good standing, and her income-driven repayment plan has not been disrupted. But with her credit compromised, she is unable to access any refinancing options for the collections debt, and she has put any larger financial moves on hold until that situation resolves one way or another.
When I left the coffee shop, Gladys was checking her phone for an update from her attorney. Before I went, she mentioned, almost as a postscript, that Mia had started kindergarten in the fall and was doing well. That, she said, was the number that mattered most to her — not the credit score, not the loan balance, not the $635 a month she was no longer spending on a pill.
“She doesn’t know any of this is happening,” Gladys told me. “I want to keep it that way.”
Her prescription assistance renewal deadline is April 30, 2026. She has already started gathering the paperwork.
Related: She Filed for Social Security at 67 — Then Learned Her Graduate School Debt Could Still Follow Her Into Retirement
Related: He Earned $80,000 a Year as a Union Electrician — Then COBRA and a Debt Garnishment Nearly Erased His Retirement
Leave a Reply